Microstructural injury to the optic nerve with vigabatrin treatment in West syndrome: A DTI study
- PMID: 40670421
- PMCID: PMC12267420
- DOI: 10.1038/s41598-025-06336-8
Microstructural injury to the optic nerve with vigabatrin treatment in West syndrome: A DTI study
Abstract
To evaluate optic nerve injury associated with vigabatrin treatment in children with West syndrome using diffusion tensor imaging. Thirty-five children with West syndrome (aged 9 days-22 months) were retrospectively analyzed and grouped as follows: (1) vigabatrin with symmetrical thalamic abnormalities, (2) vigabatrin without thalamic abnormalities, and (3) controls on other anti-seizure medications. Fractional anisotropy and apparent diffusion coefficient values of the optic nerves were assessed. ROC curves were used to determine fractional anisotropy thresholds for optic nerve injury. fractional anisotropy values in group 1 were significantly lower than those in the control group (P < 0.05), while apparent diffusion coefficient values showed no significant differences. fractional anisotropy values increased significantly after vigabatrin discontinuation (P < 0.05). ROC analysis yielded an fractional anisotropy cut-off value of 304 with 63.6% sensitivity and 100% specificity. fractional anisotropy values are a sensitive imaging biomarker for detecting vigabatrin-related optic nerve injury in West syndrome, particularly when thalamic abnormalities are present. These changes appear reversible after stopping vigabatrin.
Keywords: Cytotoxic oedema; Nuclear magnetic resonance; Optic nerve integrity; Vigabatrin.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Consent statement: The patients involved in this study, their guardians and carers all signed the informed consent form of clinical research and agreed to publish the inspection results.
Figures



Similar articles
-
Diffusion basis spectrum imaging detects axonal injury in the optic nerve following traumatic brain injury.Magn Reson Imaging. 2025 Oct;122:110451. doi: 10.1016/j.mri.2025.110451. Epub 2025 Jul 1. Magn Reson Imaging. 2025. PMID: 40609711
-
Treatment of infantile spasms.Cochrane Database Syst Rev. 2003;(3):CD001770. doi: 10.1002/14651858.CD001770. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2008 Oct 08;(4):CD001770. doi: 10.1002/14651858.CD001770.pub2. PMID: 12917912 Updated.
-
Treatment of infantile spasms.Cochrane Database Syst Rev. 2013 Jun 5;2013(6):CD001770. doi: 10.1002/14651858.CD001770.pub3. Cochrane Database Syst Rev. 2013. PMID: 23740534 Free PMC article.
-
Vigabatrin for refractory partial epilepsy.Cochrane Database Syst Rev. 2013 Jan 31;(1):CD007302. doi: 10.1002/14651858.CD007302.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2020 Jul 30;7:CD007302. doi: 10.1002/14651858.CD007302.pub3. PMID: 23440814 Updated.
-
Treatment of infantile spasms.Cochrane Database Syst Rev. 2002;(2):CD001770. doi: 10.1002/14651858.CD001770. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2003;(3):CD001770. doi: 10.1002/14651858.CD001770. PMID: 12076419 Updated.
References
-
- Ben-Menachem E.Vigabatrin. Epilepsia. .36(Suppl 2): S95–S104.6.10.1111/j.1528-1157.1995.tb06003.x (1995). - PubMed
-
- Cubells, J. F. et al. In vivo action of enzyme-activated irreversible inhibitors of glutamic acid decarboxylase and gammaaminobutyric acid transaminase in retina vs.brain. J. Pharmacol. Exp. Ther.238, 508–514 (1986). - PubMed
-
- Neal, M. J. et al. Immunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retina. Neurosci Lett.98, 29–32. 10.1016/0304-3940(89)90368-6 (1989). - PubMed
-
- Sills, G. J. et al. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects onenzymes and intermediates of the GABA shunt in rat brain and retina. Epilepsia44, 886–892. 10.1046/j.1528-1157.2003.04203.x (2003). - PubMed
-
- Fejerman, N. et al. Vigabatrin as a first-choice drug in the treatment of West syndrome. J. Child Neurol.10.1177/088307380001500304 (2000). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical